Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD — Stella

Home/Attention Deficit Hyperactivity Disorder (ADHD)/The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD

View on ClinicalTrials.gov

Recruiting

Back to Attention Deficit Hyperactivity Disorder (ADHD) trials

The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Israel

Shamir Medical Center, Ẕerifin

Key details

Phase

Safety & dosing

Sponsor

Bazelet Nehushtan LtD.

Enrollment target

~120 participants

Started

August 2024

Primary completion

August 2026

Age range

6 Years – 18 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.